Physician profile
Caleb E Mercado
NPI 1174532600
$8,095.00
in general payments reported to CMS, 2019-2025
29 companies · $2,913 in 2025
The $2,913 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,222 · 2020: $246 · 2021: $201 · 2022: $300 · 2023: $894 · 2024: $1,320 · 2025: $2,913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,987 · Travel and Lodging: $1,086 · Gift: $53.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,986.91 |
| Travel and Lodging | $1,085.70 |
| Gift | $53.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,059.70 | 2019-2025 | Impella |
| Boston Scientific Corporation | $1,986.02 | 2019-2025 | Bodyguardian, Avvigo Guidance System |
| Shockwave Medical, INC | $1,224.60 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kestra Medical Technology Services, INC. | $722.99 | 2023-2025 | Assure Wcd |
| Medtronic, INC. | $412.89 | 2021-2025 | Resolute Onyx, Symplicity G3, Linq II |
| Amgen INC. | $174.05 | 2023-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $158.11 | 2019-2022 | |
| Pfizer INC. | $157.49 | 2019-2025 | |
| Penumbra, INC. | $153.42 | 2025 | Penumbra System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $128.05 | 2024-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $113.68 | 2024-2025 | Onpattro |
| Medtronic Vascular, INC. | $110.24 | 2019 | |
| Teleflex LLC | $105.63 | 2025 | Turnpike |
| Novartis Pharmaceuticals Corporation | $93.90 | 2023-2025 | |
| Atricure, INC. | $69.39 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $67.15 | 2019-2023 | Diamondback Coronary |
| Biosense Webster, INC. | $54.32 | 2024 | Nuvision Ice Catheter |
| Merck Sharp & Dohme LLC | $41.58 | 2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $38.07 | 2024 | Wainua, Farxiga |
| Philips North America LLC | $35.98 | 2024 | (5091) Amb Mon & Diag Und |
| Cvrx, INC. | $29.04 | 2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $28.49 | 2022-2025 | Camzyos |
| Ge Healthcare | $25.18 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.39 | 2025 | |
| Edwards Lifesciences Corporation | $21.35 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $19.57 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $15.78 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $14.92 | 2024 | |
| Abbott Laboratories | $12.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Mercado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.